Recently, it was shown that patients carrying ATGL gene mutations suffer from increased systemic TAG accumulation (so called NLSD with myopathy, [10]), supporting the idea that the impaired activation of ATGL contributes to the pathogenesis of CDS. Here, PNPLA2 is linked to myopathy.